Product Information

LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0289 per EA under NDC 68180051830. Its NADAC has been published 580 times since Jul 15, 2015.

FDA first approved this application on Sep 27, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB

Lisinopril and Hydrochlorothiazide
$0.0289per EA

Strength

12.5; 10 mg/1; mg/1

NDC

68180051830

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077912

FDA Approved

9/27/2006

TE Code

AB

On Market Since

10/4/2006

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 580 times since Jul 15, 2015, and over the history we have for it it has declined 14.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0289 per EA
All-time high$0.0407 (Aug 11, 2021)
All-time low$0.0241 (Nov 20, 2024)
52-week high$0.0307
52-week low$0.0284
Median price$0.0319
Average price$0.0327
Largest weekly change+41.0% (May 22, 2019)
Weeks tracked580
Tracking sinceJul 15, 2015

Price History

1W

+0.5%

1M

+0.5%

3M

+0.7%

6M

-1.8%

1Y

-4.4%

3Y

-12.1%

5Y

-27.0%

All

-14.4%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.0289 per EA (NDC 68180051830), effective Aug 19, 2026.

How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has declined 14.4%. It has been tracked across 580 weekly CMS publications since Jul 15, 2015.

What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

Since Jul 15, 2015, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.0241 (Nov 20, 2024) to a high of $0.0407 (Aug 11, 2021), with a median of $0.0319 per EA.

Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 68180051830) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.